Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need

Article Abstract

Antipsychotic medications, as well as schizophrenia, have beenassociated with an increased risk for diabetes. However, therelative contributions of the underlying illness, unhealthy lifestylebehaviors, and medications used to treat schizophrenia arestill unclear. Although first- and second-generation antipsychoticshave been contrasted broadly in the literature regarding theirrisks for glucoregulatory abnormalities, there is now sufficientevidence to suggest that the risk for diabetes is not uniformwithin each antipsychotic class.

Volume: 70

Quick Links: Metabolic Disorder , Side Effects-Medication

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF